| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 52.0822 | 54 |
| GSM780708 | Untreated after 4 days (C2_1) | 56.4469 | 61 |
| GSM780709 | Untreated after 4 days (C3_1) | 44.8072 | 26 |
| GSM780719 | Untreated after 4 days (C1_2) | 52.8087 | 56 |
| GSM780720 | Untreated after 4 days (C2_2) | 52.3805 | 55 |
| GSM780721 | Untreated after 4 days (C3_2) | 57.0737 | 62 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 58.3904 | 63 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 53.5701 | 57 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 54.7746 | 59 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 55.9453 | 61 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.6886 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 51.9441 | 54 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 50.581 | 50 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 51.7746 | 53 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 61.1701 | 65 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.981 | 41 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 44.2818 | 24 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 55.895 | 61 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 49.6549 | 47 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.1076 | 49 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 46.5051 | 34 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.2581 | 58 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 56.263 | 61 |